South Korea’s Coronavirus Vaccination Promotion Mission said on the 11th that after fully listening to expert opinions and discussing with the vaccination committee, it decided to restart the vaccination of AstraZeneca vaccine from the 12th, but people under the age of 30 are still not recommended to get the vaccine.
The Korea Vaccination Committee pointed out that in the current situation of the continuous spread of the COVID-19 epidemic, vaccination is the key to reducing the number of deaths and reducing the scale of the COVID-19 epidemic.
So far, South Korea has reported three cases of thrombosis after being vaccinated against AstraZeneca, two of which are under the age of 30. The Special Committee on Inoculation said that two of the three cases had no direct causal relationship with vaccination; the other case, although the causal link with vaccination was confirmed, the case did not show symptoms of thrombocytopenia and therefore did not meet the European Drug Administration’s decision on the side effects of the AstraZeneca vaccine.
However, the Korea Special Committee on Inoculation pointed out that according to the analysis of the advantages and disadvantages of AstraZeneca vaccine for all ages, AstraZeneca vaccine is not recommended for people under the age of 30.
Previously, the British vaccine advisory body also said that due to thrombus problems, alternative vaccines will be provided to people under the age of 30.
Previously, the South Korean government decided to temporarily postpone the vaccination of staff in special schools and junior colleges and universities across the country, which was originally scheduled to start on the 8th, and to suspend the vaccination of AstraZeneca for people under the age of 60.
